rs104886003
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We also found that an activating (E545K) Pik3ca mutation, unlike Pten inactivation or Pik3ca H1047R mutation, cannot cooperate with Arid1a loss to promote ovarian cancer development in the mouse.
|
26279473 |
2016 |
rs121913279
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We also found that an activating (E545K) Pik3ca mutation, unlike Pten inactivation or Pik3ca H1047R mutation, cannot cooperate with Arid1a loss to promote ovarian cancer development in the mouse.
|
26279473 |
2016 |
rs2699887
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk.
|
31288947 |
2019 |
rs3976507
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.
|
31288947 |
2019 |
rs6443626
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.
|
31288947 |
2019 |
rs104886003
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs104886003
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
|
|
|
rs104886003
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913279
|
|
G |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913279
|
|
G |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs1057519925
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1057519941
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1064793732
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913272
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913272
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913273
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913274
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913274
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913281
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913286
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913286
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |